Veru Inc is trading 11.7% down at $3.00 as it continues to pull back from a massive surge triggered by its supply agreement with Novo Nordisk.
- The stock is experiencing heavy profit-taking following an 88.0% jump on June 4 and a subsequent 19.6% decline on June 5.
- With no fresh company-specific catalysts reported for June 8, the move appears to be a continued unwinding of the recent event-driven rally.
- The decline comes despite broader U.S. equities remaining mixed to firmer, suggesting the selloff is isolated to the stock's recent volatility.